RADIQAL Study (Radiation Dose and Image Quality Trial)
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 824 participants.
Also called NCT06944509
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose other
- Phase
- Not applicable
- Enrolled
- 824 participants
- Registry
-
NCT06944509
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Czechia, Denmark, Spain
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06944509. Randomized; no masking; primary purpose other. Start 2025-05-14 (actual); primary completion 2027-03-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- RADIQAL Study (Radiation Dose and Image Quality Trial)
- Acronym
- RADIQAL
- Condition
- Coronary Artery Disease
- Intervention (Device)
- treatment with the Azurion system with Xres5
- Intervention (Other)
- Azurion with Clairy IQ
- Lead sponsor
- Philips Clinical & Medical Affairs Global
Record details
- Record id
cardio:ct-nct06944509- Content hash
fa2993bda0ff4ec71f834001ee44789400ca0d3eccebef871f0668c39fe39bde